Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

OBJECTIVE: Determine if incident AIDS-defining Kaposi sarcoma (KS) or Pneumocystis jiroveci pneumonia (PJP) is associated with combination antiretroviral therapy (cART) initiation. DESIGN: Compare risk for KS and PJP by time on cART and CD4 reconstitution. METHODS: In the FHDH-ANRS CO4 cohort (N=66,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lacombe, Jean-Marc, Boue, François, Grabar, Sophie, Viget, Nathalie, Gazaignes, Sandrine, Lascaux-Cametz, Anne-Sophie, Pacanowski, Jérome, Partisani, Marialuisa, Launay, Odile, Matheron, Sophie, Rosenthal, Eric, Rouveix, Elisabeth, Tattevin, Pierre, de Truchis, Pierre, Costagliola, Dominique, Goedert, James J
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623279/
https://ncbi.nlm.nih.gov/pubmed/23196937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32835cba6c
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki